Integra Price To Sales Ratio from 2010 to 2025
| IART Stock | USD 24.10 0.86 3.70% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 2.54 | Current Value 4.18 | Quarterly Volatility 2.9420044 |
Check Integra LifeSciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Integra LifeSciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 149.1 M, Interest Expense of 62 M or Total Revenue of 1.9 B, as well as many indicators such as Price To Sales Ratio of 4.18, Dividend Yield of 3.0E-4 or PTB Ratio of 3.52. Integra financial statements analysis is a perfect complement when working with Integra LifeSciences Valuation or Volatility modules.
Integra | Price To Sales Ratio |
Latest Integra LifeSciences' Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of Integra LifeSciences Holdings over the last few years. Price to Sales Ratio is figured by comparing Integra LifeSciences stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Integra LifeSciences sales, a figure that is much harder to manipulate than other Integra LifeSciences Holdings multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Integra LifeSciences' Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Integra LifeSciences' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 1.19 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
Integra Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 3.40 | |
| Geometric Mean | 2.81 | |
| Coefficient Of Variation | 86.45 | |
| Mean Deviation | 1.52 | |
| Median | 2.99 | |
| Standard Deviation | 2.94 | |
| Sample Variance | 8.66 | |
| Range | 12.8312 | |
| R-Value | (0.21) | |
| Mean Square Error | 8.88 | |
| R-Squared | 0.04 | |
| Significance | 0.44 | |
| Slope | (0.13) | |
| Total Sum of Squares | 129.83 |
Integra Price To Sales Ratio History
About Integra LifeSciences Financial Statements
Integra LifeSciences shareholders use historical fundamental indicators, such as Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Integra LifeSciences investors may analyze each financial statement separately, they are all interrelated. The changes in Integra LifeSciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Integra LifeSciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 2.54 | 4.18 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Integra Stock Analysis
When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.